Skip to Main Content

President Trump’s promise to “slash the restraints” at the Food and Drug Administration appeared to lay down a marker for sweeping deregulation — and the Twittersphere reacted with both cheers and jeers.

During his address to a joint session of Congress on Tuesday night, Trump decried a “slow and burdensome” regulatory process that he said has too often delayed access to new treatments. He promised to bring about swift change. If there is an avalanche of new medicines, however, their manufacturers had better keep the costs in check, since Trump also vowed — without specifics — to bring down drug prices immediately. That particular bit of his speech drew a rare bipartisan standing ovation.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!